VANGUARD HEALTH CARE INV VGHCX
EQUITY FUNDS · Open-End Fund · CUSIP 921908307
3
institutional holders
+1 vs Q3 2023
19.1k
shares reported held*
$4.0mreported value*
0 new
1 added
1 reduced
0 sold out
net sold ≈ $17.4k (-83 shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $209.14.
Trends to Q4 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 1 |
| Q4 2022 | 2 |
| Q1 2023 | 3 |
| Q2 2023 | 4 |
| Q3 2023 | 2 |
| Q4 2023 | 3 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 0 | 1 |
| Q1 2023 | 3 | 0 |
| Q2 2023 | 1 | 1 |
| Q3 2023 | 0 | 3 |
| Q4 2023 | 1 | 1 |
Biggest buyers
| Jackson Wealth Management, LLC | Added | +42 |
Biggest sellers
| Fairfield Financial Advisors, LTD | Reduced | -125 |
Holders, Q4 2023
| Manager | Shares | Change |
|---|---|---|
| Fairfield Financial Advisors, LTD 1.43% of their portfolio | 18.0k $3.8m | Reduced -125 |
| Jackson Wealth Management, LLC 0.03% of their portfolio | 1.1k $232.0k | Added +42 |
| Main Street Group, LTD 0.00% of their portfolio | 35 $7.5k | First filing |